The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 20.64%. However, over the past six months, we’ve seen a weaker performance of 13.38%. The price of REPL leaped by -0.49% over the last 30 days. And in the last five days, it has surged by 0.30%.
The stock market performance of Replimune Group Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $21.32 on 08/31/23, while the lowest price during the same time frame was $4.92, recorded on 05/29/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of REPL Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Replimune Group Inc’s current trading price is -52.30% away from its 52-week high, while its distance from the 52-week low is 106.71%. The stock’s price range for this period has been between $4.92 and $21.32. The Healthcare sector company’s shares saw a trading volume of about 0.97 million for the day, which was lower than the average daily volume of 1.1 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Replimune Group Inc (REPL) has experienced a quarterly rise of 92.98% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 694.81M and boasts a workforce of 331 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.23, with a change in price of +2.89. Similarly, Replimune Group Inc recorded 983,591 in trading volume during the last 100 days, posting a change of +39.70%.
REPL’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for REPL stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.17.
REPL Stock Stochastic Average
As of today, the raw stochastic average of Replimune Group Inc over the past 50 days is 66.76%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 49.43%. Additionally, the Stochastic %K and %D values for the company were 70.85% and 70.64%, respectively, over the past 20 days.
